WHO ICTRP trial
Is Diosmin (Venusmin) effective in treating haemorrhoids
CTRI/2020/11/028921 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/11/028921 |
|---|---|
| Public title | Is Diosmin (Venusmin) effective in treating haemorrhoids |
| Scientific title | A prospective randomized double blind controlled study to evaluate the efficacy and safety of Venusmin 900mg, a 100% pure and micronized Oral Diosmin in the cessation of bleeding and symptoms associated with haemorrhoids |
| Primary sponsor | Walter Bushnell Laboratories Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: K649- Unspecified hemorrhoids |
| Interventions | Intervention1: Oral 100% pure micronised diosmin, with Ispaghula husk: 900mg tablet orally twice a day for 7 days, followed by 900mg once a day for a further 5 weeks, to make a total of 6 weeks therapy. 3.5g of Ispaghula husk will be given… |
| Registration date | May 11, 2020 |
| Target size | 110 |
| Secondary IDs | WBL/Diosmin 16/Dec/2018 ver 2.0 dated 21.09.2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: